Neumora Therapeutics IncNASDAQ:NMRA
- LAST PRICE13.5400
- TODAY'S CHANGE (%)0.5200 (3.9939%)
- Bid / Lots13.7400/ 1
- Ask / Lots13.7500/ 1
- Open / Previous Close13.0500 / 13.0200
- Day Range
- 52 Week Range
- Volume1,272,120
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMRA |
|---|---|---|
| 09:32 ET | 3983 | 13.13 |
| 09:33 ET | 1100 | 13.17 |
| 09:35 ET | 600 | 13.065 |
| 09:37 ET | 926 | 13.25 |
| 09:39 ET | 600 | 13.18 |
| 09:42 ET | 1340 | 13.17 |
| 09:44 ET | 300 | 13.1 |
| 09:46 ET | 1328 | 13.13 |
| 09:48 ET | 1900 | 13.095 |
| 09:50 ET | 1600 | 13.1 |
| 09:51 ET | 400 | 13.105 |
| 09:53 ET | 300 | 13.23 |
| 09:55 ET | 2465 | 13.18 |
| 09:57 ET | 2754 | 13.2499 |
| 10:00 ET | 500 | 13.185 |
| 10:02 ET | 368 | 13.17 |
| 10:04 ET | 1502 | 13.2 |
| 10:06 ET | 2419 | 13.24 |
| 10:08 ET | 850 | 13.2 |
| 10:09 ET | 2349 | 13.13 |
| 10:11 ET | 3446 | 13.065 |
| 10:13 ET | 5374 | 13.16 |
| 10:15 ET | 1253 | 13.15 |
| 10:18 ET | 9057 | 13.09 |
| 10:20 ET | 519 | 13.04 |
| 10:22 ET | 3054 | 13.16 |
| 10:24 ET | 317 | 13.12 |
| 10:26 ET | 1854 | 13.17 |
| 10:27 ET | 519 | 13.17 |
| 10:29 ET | 29823 | 13.165 |
| 10:31 ET | 5021 | 13.12 |
| 10:33 ET | 1498 | 13.13 |
| 10:36 ET | 6444 | 13.215 |
| 10:38 ET | 912 | 13.21 |
| 10:40 ET | 1239 | 13.24 |
| 10:42 ET | 2651 | 13.21 |
| 10:44 ET | 1205 | 13.21 |
| 10:45 ET | 1474 | 13.19 |
| 10:47 ET | 8152 | 13.265 |
| 10:49 ET | 3389 | 13.25 |
| 10:51 ET | 8753 | 13.275 |
| 10:54 ET | 5251 | 13.315 |
| 10:56 ET | 3584 | 13.38 |
| 10:58 ET | 3250 | 13.39 |
| 11:00 ET | 3998 | 13.29 |
| 11:02 ET | 3600 | 13.32 |
| 11:03 ET | 1000 | 13.29 |
| 11:05 ET | 3558 | 13.295 |
| 11:07 ET | 811 | 13.25 |
| 11:09 ET | 5951 | 13.19 |
| 11:12 ET | 1601 | 13.13 |
| 11:14 ET | 1550 | 13.14 |
| 11:16 ET | 1326 | 13.155 |
| 11:18 ET | 1600 | 13.2 |
| 11:20 ET | 4100 | 13.24 |
| 11:21 ET | 915 | 13.25 |
| 11:23 ET | 7045 | 13.26 |
| 11:25 ET | 1013 | 13.27 |
| 11:27 ET | 2615 | 13.26 |
| 11:30 ET | 3262 | 13.215 |
| 11:32 ET | 1401 | 13.215 |
| 11:34 ET | 2100 | 13.155 |
| 11:36 ET | 2515 | 13.2 |
| 11:38 ET | 7663 | 13.225 |
| 11:39 ET | 200 | 13.2 |
| 11:41 ET | 3306 | 13.27 |
| 11:43 ET | 1223 | 13.23 |
| 11:45 ET | 916 | 13.25 |
| 11:48 ET | 1600 | 13.27 |
| 11:50 ET | 510 | 13.275 |
| 11:52 ET | 2019 | 13.24 |
| 11:54 ET | 1322 | 13.26 |
| 11:56 ET | 855 | 13.26 |
| 11:57 ET | 1280 | 13.23 |
| 11:59 ET | 957 | 13.23 |
| 12:01 ET | 6686 | 13.3 |
| 12:03 ET | 250 | 13.31 |
| 12:06 ET | 1694 | 13.36 |
| 12:08 ET | 1677 | 13.33 |
| 12:10 ET | 600 | 13.3 |
| 12:14 ET | 900 | 13.29 |
| 12:15 ET | 2251 | 13.265 |
| 12:17 ET | 800 | 13.265 |
| 12:19 ET | 600 | 13.275 |
| 12:21 ET | 3048 | 13.35 |
| 12:24 ET | 1400 | 13.345 |
| 12:26 ET | 4339 | 13.41 |
| 12:28 ET | 562 | 13.39 |
| 12:30 ET | 200 | 13.39 |
| 12:32 ET | 3687 | 13.355 |
| 12:33 ET | 2000 | 13.39 |
| 12:35 ET | 1600 | 13.36 |
| 12:37 ET | 5137 | 13.37 |
| 12:42 ET | 1570 | 13.35 |
| 12:44 ET | 972 | 13.35 |
| 12:46 ET | 2113 | 13.37 |
| 12:48 ET | 1238 | 13.38 |
| 12:50 ET | 616 | 13.38 |
| 12:51 ET | 3118 | 13.41 |
| 12:53 ET | 1600 | 13.4 |
| 12:55 ET | 2746 | 13.4 |
| 12:57 ET | 1300 | 13.41 |
| 01:00 ET | 1566 | 13.405 |
| 01:02 ET | 4967 | 13.405 |
| 01:04 ET | 4980 | 13.4 |
| 01:06 ET | 2989 | 13.42 |
| 01:08 ET | 1217 | 13.445 |
| 01:09 ET | 2643 | 13.46 |
| 01:11 ET | 1642 | 13.49 |
| 01:13 ET | 2007 | 13.48 |
| 01:15 ET | 5873 | 13.445 |
| 01:18 ET | 1083 | 13.445 |
| 01:20 ET | 2245 | 13.445 |
| 01:22 ET | 2196 | 13.445 |
| 01:24 ET | 2372 | 13.44 |
| 01:26 ET | 4212 | 13.455 |
| 01:27 ET | 3050 | 13.46 |
| 01:29 ET | 15133 | 13.47 |
| 01:31 ET | 4467 | 13.44 |
| 01:33 ET | 2771 | 13.44 |
| 01:36 ET | 2254 | 13.47 |
| 01:38 ET | 900 | 13.46 |
| 01:40 ET | 1169 | 13.475 |
| 01:42 ET | 985 | 13.48 |
| 01:44 ET | 25278 | 13.47 |
| 01:45 ET | 1600 | 13.47 |
| 01:47 ET | 1661 | 13.49 |
| 01:49 ET | 3828 | 13.48 |
| 01:51 ET | 2600 | 13.475 |
| 01:54 ET | 1896 | 13.475 |
| 01:56 ET | 3283 | 13.47 |
| 01:58 ET | 3213 | 13.48 |
| 02:00 ET | 8658 | 13.445 |
| 02:02 ET | 7681 | 13.39 |
| 02:03 ET | 4974 | 13.36 |
| 02:05 ET | 7456 | 13.45 |
| 02:07 ET | 1306 | 13.44 |
| 02:09 ET | 1060 | 13.46 |
| 02:12 ET | 1600 | 13.43 |
| 02:14 ET | 2353 | 13.425 |
| 02:16 ET | 3878 | 13.41 |
| 02:18 ET | 4363 | 13.43 |
| 02:20 ET | 3246 | 13.41 |
| 02:21 ET | 211 | 13.41 |
| 02:23 ET | 1255 | 13.41 |
| 02:25 ET | 5552 | 13.43 |
| 02:27 ET | 1300 | 13.43 |
| 02:30 ET | 1100 | 13.42 |
| 02:32 ET | 3706 | 13.445 |
| 02:34 ET | 600 | 13.44 |
| 02:36 ET | 1540 | 13.45 |
| 02:38 ET | 1750 | 13.43 |
| 02:39 ET | 500 | 13.43 |
| 02:41 ET | 1610 | 13.42 |
| 02:43 ET | 26825 | 13.46 |
| 02:45 ET | 12584 | 13.45 |
| 02:48 ET | 1200 | 13.44 |
| 02:50 ET | 1017 | 13.44 |
| 02:52 ET | 540 | 13.44 |
| 02:54 ET | 8109 | 13.45 |
| 02:56 ET | 6353 | 13.48 |
| 02:57 ET | 40904 | 13.415 |
| 02:59 ET | 8726 | 13.4 |
| 03:01 ET | 9958 | 13.425 |
| 03:03 ET | 7090 | 13.44 |
| 03:06 ET | 6991 | 13.465 |
| 03:08 ET | 1576 | 13.485 |
| 03:10 ET | 1916 | 13.46 |
| 03:12 ET | 1100 | 13.45 |
| 03:14 ET | 7710 | 13.44 |
| 03:15 ET | 3254 | 13.44 |
| 03:17 ET | 4967 | 13.43 |
| 03:19 ET | 3409 | 13.455 |
| 03:21 ET | 783 | 13.445 |
| 03:24 ET | 1200 | 13.445 |
| 03:26 ET | 1200 | 13.405 |
| 03:28 ET | 2418 | 13.43 |
| 03:30 ET | 6900 | 13.44 |
| 03:32 ET | 4974 | 13.485 |
| 03:33 ET | 1915 | 13.48 |
| 03:35 ET | 1600 | 13.49 |
| 03:37 ET | 5086 | 13.455 |
| 03:39 ET | 2531 | 13.45 |
| 03:42 ET | 4404 | 13.45 |
| 03:44 ET | 2547 | 13.4075 |
| 03:46 ET | 14442 | 13.455 |
| 03:48 ET | 2750 | 13.47 |
| 03:50 ET | 4461 | 13.469 |
| 03:51 ET | 3793 | 13.48 |
| 03:53 ET | 12093 | 13.465 |
| 03:55 ET | 10716 | 13.48 |
| 03:57 ET | 23118 | 13.47 |
| 04:00 ET | 210145 | 13.54 |
Nov 6, 2024
Neumora Therapeutics to Participate in Upcoming Conferences in November, from 7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
DJ Neumora Therapeutics Cut to Neutral From Overweight by JP Morgan, from 7:25AM ET on Tuesday Nov 05, 2024 by Dow Jones
7:25AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 29, 2024
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024, from 7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
7:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
Oct 18, 2024
DJ Neumora Therapeutics Price Target Maintained With a $23.00/Share by Needham, from 6:16AM ET on Friday Oct 18, 2024 by Dow Jones
6:16AM ET on Friday Oct 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neumora Therapeutics Inc | 2.2B | -8.1x | --- |
Structure Therapeutics Inc | 2.2B | -17.0x | --- |
Centessa Pharmaceuticals PLC | 2.1B | -10.6x | --- |
NewAmsterdam Pharma Company NV | 2.2B | -10.8x | --- |
Spyre Therapeutics Inc | 2.0B | -2.6x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -27.7x | --- |
Company Information
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Contact Information
- Headquarters
- 490 Arsenal Way, Suite 200WATERTOWN, MA, United States 02472
- Phone
- 857-760-0900
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, Co-Founder
- Paul Berns
- President, Chief Executive Officer, Director
- Henry Gosebruch
- Co-Founder, Chief Operating Officer
- Carol Suh
- Chief Financial Officer
- Joshua Pinto
- Chief Strategy Officer
- Daljit Aurora
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.66 |
Book Value | $2.95 |
P/E Ratio | -8.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
